A detailed history of Harbor Capital Advisors, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 30,442 shares of EBS stock, worth $222,226. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,442
Previous 36,904 17.51%
Holding current value
$222,226
Previous $179,000 8.38%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025

SELL
$4.26 - $6.94 $27,528 - $44,846
-6,462 Reduced 17.51%
30,442 $194,000
Q1 2025

Apr 14, 2025

BUY
$4.66 - $11.66 $171,972 - $430,300
36,904 New
36,904 $179,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $364M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.